C20 – Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Liver Malignancies; a Newly Observed Complication

Published in 2009 Listed under Clinical, Poster

Steven Naymagon, Richard R.P. Warner, Kalpesh Patel, Josef Machac, Joshua L. Weintraub, Michelle K. Kim

  pdf Download Poster (66 KB)

C20 – Pattern and Clinical Predictors of Lymph Node Involvement in Neuroendocrine Neoplasms of the Pancreas

Published in 2011 Listed under Clinical, Poster

Stefano Partelli, Rim Cherif, Letizia Boninsegna, Sebastien Gaujoux, Stefano Crippa, Anne Couvelard, Aldo Scarpa, Alain Sauvanet, Philippe Ruszniewski

  pdf Download Poster (862 KB)

C21 - Lymphovascular Invasion, Tumor Growth Pattern and Fibrosis in Pancreatic Neuroendocrine Tumors: Qualitative Imaging Correlates on Preoperative CT/MRI in a Series of 136 Cases

Published in 2019 Listed under Clinical

Motoyo Yano; Nikolaos Trikalinos;Greg Williams; Amber Salter; Samantha Lancia; Chet Hammill; William Hawkins; Deyali Chatterjee

Abstract ID: 29

C21 - Prospective Observational Study in Patients with Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated with Lanreotide Depot in a US Community Oncology Setting: Interim Analysis

Published in 2018 Listed under Clinical, Poster

Abstract ID: 95

Andrew Paulson, Beloo Mirakhur, David Ray, Eric Liu, Allen Cohn, David Cosgrove, Donald Richards, Richard Siegel, Yunfei Wang, Sharan Aranha, Yolanda Caddick, Amy Scales, Kathy Allen,  Sonia Pulgar

  pdf Download Poster (8.34 MB)

C21 – Effect of Short-term Proton Pump Inhibitor Treatment and Its Discontinuation on Chromogranin A in Healthy Subjects

Published in 2012 Listed under Clinical, Poster

Walter Kocha MD; Hala H. Mosli MBBS, FRCP(c), ABIM, ABEM, Cert Endo; Alan Dennis PhD, FCACB, MBA ; Linda J. Asher RN; Stan H.M. Van Uum, MD PhD, FRCP(c)

  pdf Download Poster (2.00 MB)

C21 – Multicenter Prospective Phase II Trial of Bevacizumab (bev) for Progressive Pancreatic Neuroendocrine Tumor (PNET)

Published in 2015 Listed under Clinical

Hobday; Yin; Pettinger; Strosberg; Reidy Lagunes; Chen; Erlichman; Lee

C21 – Phase I Trial of 90Y-DOTA-tyr3-Octreotide in Children and Young Adults

Published in 2009 Listed under Clinical

M. Sue O’Dorisio, Yusuf Menda, Stacy Michael, Simon Kao, Geetika Khanna, Mary Connelly, John Babich, Thomas O’Dorisio, David Bushnell, M.D., Mark Madsen

C21 – Treatment of Pancreatic Neuroendocrine Tumors (pNET) With Everolimus: Improved Progression-Free Survival Compared With Placebo (RADIANT-3)

Published in 2010 Listed under Clinical

Manisha H. Shah, Kjell Öberg, Tetsuhide Ito, Catherine Lombard-Bohas, Edward M. Wolin, Eric Van Cutsem, Carolin Sachs, Robert Winkler, Jeremie Lincy, Timothy Hobday and James C. Yao

C22 - Evaluation of Small Bowel Neuroendocrine Tumor Metastases by 68Ga-DOTATATE PET/CT: A Single Institution Review

Published in 2019 Listed under Clinical

Hannah Monahan; Ajit Goenka; Michael Wells; Stephen Broski; Annie Packard; Thorvardur Halfdanarson

Abstract ID: 30

C22 – Cystic Neuroendocrine Tumors of the Pancreas (c-pNETs): Single- Center Experience

Published in 2015 Listed under Clinical

Kommineni; Coakley; Pannala; Chen; Zhang; Wasif; Halfdanarson

C22 – Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs):

Published in 2009 Listed under Clinical, Poster

Ike Onwere, Thomas O’Dorisio, Sue M. O’Dorisio, Barry DeYoung, Menda Yusuf

  pdf Download Poster (319 KB)

C22 – Generator Produced 68Ga for Clinical Preparations of [68Ga]DOTATOC for Imaging Neuroendocrine Tumor Patients: Initial Studies at the University of Iowa

Published in 2011 Listed under Clinical, Poster

Michael K. Schultz; Yusuf Menda; Thomas O'Dorisio; Laura L. Boles Ponto; Kathy Thedes-Reynolds; John J. Sunderland; David L. Bushnell; G. Leonard Watkins; M. Sue O'Dorisio

  pdf Download Poster (6.49 MB)

C23 - Initial Experience with Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETs) at a Tertiary Care United States Center

Published in 2019 Listed under Clinical

Jason Heckert; Samuel Botterbusch; Sarit Kipnis; Bonita Bennet; Caroline Creamer; Alice Alderson; Jennifer Eads; Michael Soulen; Daniel Pryma; David Mankoff; David Metz; Bryson Katona

Abstract ID: 40

C23 - The Sequencing of Lanreotide (LAN) After Octreotide LAR (OCT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Published in 2018 Listed under Clinical, Poster

 Abstract ID: 36

Wasif M. Saif1, Rohan C. Parikh, David Ray, James A. Kaye, Samantha K. Kurosky, Katharine Thomas, Thorvardur R. Halfdanarson, Thomas Beveridge, Beloo Mirakhur, Catherine A. Lubeck, Saurabh Nagar

pdf Download Poster (8.31 MB)

C23 – A Multi-Institutional Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Published in 2012 Listed under Clinical

Matthew H. Kulke; Jennifer A. Chan; David P. Ryan; Jeffrey A. Meyerhardt; Charles S. Fuchs; Thomas Abrams; Eileen Regan; Rachel Brady; Jill Weber; Tiffany Campos; Larry K. Kvols; Jonathan R. Strosberg

C23 – Phase II Study of Temozolomide for Relapsed Sensitive or Refractory

Published in 2009 Listed under Clinical, Poster

M. Catherine Pietanza, William D. Travis, Timothy A. Chan, Michelle S. Ginsberg, Andrei Holodny Mark G. Kris, Lee M. Krug

  pdf Download Poster (385 KB)

C23 – Neuroendocrine Tumor Collaborative Registry

Published in 2011 Listed under Clinical, Poster

Oleg Shats, Jean F. Botha, Jean Grem, Lucienne Case, Alexander Sherman, Janmin Feng, Greg Wilson, Simon Sherman

  pdf Download Poster (286 KB)

C24 - Granulomatous Fungal Infection Coexistence with NET: Not All That Lights Up on PET Scan is a NET

Published in 2019 Listed under Clinical

Ayca Dundar; Thorvardur Halfdanarson; Ayse Tuba Kendi; Saul Friedman; Michael Bold; Rachel Eiring; Geoffrey Johnson

Abstract ID: 48

C24 - Patient-Reported Symptom Burden of Carcinoid Syndrome Diarrhea Inadequately Controlled by Somatostatin Analog Therapy

Published in 2018 Listed under Clinical, Poster

Abstract ID: 29

Jonathan Strosberg, Vijay N. Joish, Chad McKee, Susan Giacalone, Raul Perez-Olle, Ann Fish-Steagall, Kanika Kapoor, Sam Dharba, Al B. Benson

  pdf Download Poster (1.08 MB)

C24 – Phase II study of sunitinib malate following hepatic artery embolization for metastatic neuroendocrine tumors

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Tiffany Campos, Tiffany Valone PA, Larry Kvols MD

  pdf Download Poster (6.15 MB)

C24 – Sunitinib versus Placebo for the Treatment of Progressive, Well-Differentiated Pancreatic Islet Cell Tumors: A Phase III, Randomized, Double-Blind Trial

Published in 2009 Listed under Clinical

Eric Raymond, Jean-Luc Raoul, Patricia Niccoli, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Peter Metrakos, Dongrui-Ray Lu, Carolyn Blanckmeister, Aaron Vinik

C24 – Telotristat Etiprate Shows Benefit in Treating Patients with Carcinoid Syndrome that is Inadequately Controlled by Somatostatin Analog Therapy in the Phase 3 TELESTAR Clinical Trial

Published in 2015 Listed under Clinical

Kulke; Horsch; Caplin; Anthony; Anthony; Bergsland; Oberg; Welin; Warner; Lombard-Bahas; Kunz; Grande; Valle; Fleming; Lapuerta; Banks; Jackson; Wheeler; Zambrowicz; Sands; Pavel

C24 – The Prevalence of Over the Counter Medication Use Among Patients with Midgut Neuroendocrine Tumors

Published in 2012 Listed under Clinical

Erika B. Lindholm, MD; Maneesh K. Gupta, MD; Anne Diebold BS; JP Boudreaux MD; Yi Z. Wang, MD; Eugene A. Woltering MD

C25 - A Personalized Remote Radiation-Tracking Vest for At-Home Monitoring of Lu-177 DOTATATE Therapy

Published in 2019 Listed under Clinical

Larry Pierce; Robert Harrison; Hubert Vesselle; Robert Miyaoka

Abstract ID: 56

C25 - Capecitabine/Temozolomide Chemotherapy in Metastatic Neuroendocrine Tumors - Response Rate and Survival by Grade

Published in 2018 Listed under Clinical, Poster

 Abstract ID: 104

Katharine Thomas, Ryan Griffin, Brianne Voros, J. Phillip Boudreaux, Ramcharan Thiagarajan, Eugene Woltering, Robert Ramirez

pdf Download Poster (1.56 MB)

C25 – Prognostic Relevance of a Novel AJCC Staging Classification for Neuroendocrine Tumors of the Pancreas

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Jill Weber MPH, Domenico Coppola MD, Larry Kvols MD

  pdf Download Poster (5.41 MB)

C25 – Surveillance of Small Rectal Carcinoid Tumors in the Absence of Metastatic Disease

Published in 2012 Listed under Clinical, Poster

Sara E. Murray, MD; Rebecca S. Sippel, MD, FACS; Ricardo Lloyd, MD., PhD; Herbert Chen, MD, FACS

  pdf Download Poster (2.66 MB)

C25 – Multi-Feature Method for Ascertaining NET Cases in a Clinical Data Warehouse

Published in 2011 Listed under Clinical, Poster

Marie Synnestvedt PhD, Bonnie Bennett RN, BSN, Hillary Faust MD, Mark Weiner MD, David C. Metz MD

  pdf Download Poster (179 KB)

C26 - Intra-Arterial Peptide Receptor Radionuclide Therapy Using Y-90 DOTATOC for Hepatic Metastases of Gastroenteropancreatic Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Courtney Lawhn Heath; Nicholas Fidelman; Emily Bergsland; Thomas Hope

Abstract ID: 59

C26 - Pembrolizumab (P) Monotherapy in Patients with Previously Treated Metastatic High Grade Neuroendocrine Neoplasms (HG-NENs)

Published in 2018 Listed under Clinical, Poster

Abstract ID: 34

Namrata Vijayvergia, Arvind Dasari, Karen Ruth, Efrat Dotan, Daniel Halperin, Igor Astsaturov, Michael J Hall, Denlinger Crystal, Steven J Cohen, Paul F Engstrom

  pdf Download Poster (255 KB)

C26 – Initial Evaluation of Patients with NETS: A Prospective Evaluation of the Influence of Intensive Pre-Visit Counseling

Published in 2009 Listed under Clinical

Pamela Ryan BSN RN, Jarret Brashear BS, Yi-Zarn Wang MD, Lowell B. Anthony MD, J. Philip Boudreaux MD, Saju Joseph MD, Richard Campeau MD and Eugene A. Woltering MD

C26 – Risk of Metastatic Spread in Patients with Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Jill Weber MPH, Domenico Coppola MD, Larry Kvols MD

  pdf Download Poster (5.57 MB)

C26 – Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Carcinoid Syndrome: Update of a Phase 2, Multicenter, Open-label, Serial-ascending, European Study

Published in 2012 Listed under Clinical

Marianne Pavel; Bertram Wiedenmann; Martyn Caplin, Dieter Hoersch; Joel Freiman; Linda Law; Phillip Banks; Kenny Frazier; Jessica Jackson; Brian Zambrowicz

C26 – Comparison of 68Ga-somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma

Published in 2011 Listed under Clinical, Poster

Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Diana Salvo; Stefano Fanti; Alessandro Giordano; Vittoria Rufini

  pdf Download Poster (12.37 MB)

C27 - Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid

Published in 2018 Listed under Clinical, Poster

Abstract ID: 57

Xin Wang, Yuan Liang Li, Jiang Hui Duan, Ying Ying Chen, Bing Yuan, Zhi Rong Qi, Huang Ying Tan

  pdf Download Poster (548 KB)

C27 - First U.S. Prospective Evaluation of Performance of Cu-64 DOTATATE PET/CT in Somatostatin Expressing Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Ebrahim Delpassand; Rodolfo Nuñez; David Ranganathan; Nilesh Wagh; Afshin Shafie; Ayman Gaber; Ali Abbasi

Abstract ID: 63

C27 – First-Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide

Published in 2009 Listed under Clinical

Jonathan Strosberg MD, Junsung Choi MD, Aejaz Nasir MD, Larry Kvols MD

C27 – Histological Classification of Pancreatic Neuroendocrine Tumours: Optimizing the Ki67 Range for Grade of Tumours

Published in 2015 Listed under Clinical

Mills; Rampage; Prachalias; Srinivasan; Menon; Quaglia; Vivian; Heaton; Sarker; Ross; Sriiajaskanthan

C27 – Interim Results of an Open-Label, Single-Arm Trial of Ultratrace I-131-Iobenguane in Patients with Metastatic Pheochromocytoma/Paraganglioma (Pheo)

Published in 2012 Listed under Clinical, Poster

Daniel A Pryma; R Edward Coleman; Richard Noto; Rodolfo F Perini; Camilo Jimenez; Miguel Pampaloni; Aldo Serafini; Richard Wahl; Lale Kostakoglu; Perry W.Grigsy; Julie Schwarz; Kathy Ford; Jennifer Conley; Norman LaFrance; John Barrett; John Babich

  pdf Download Poster (223 KB)

C27 – Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well-Differentiated Pancreatic Neuroendocrine Tumor (NET)

Published in 2011 Listed under Clinical, Poster

Aaron Vinik, Eric Van Cutsem, Patricia Niccoli, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan W. Valle, Peter Metrakos, Denis Smith, Jen-Shi Chen, Dieter Hörsch, Daniel E. Castellano, Hagen F. Kennecke, Joel Picus, Guy Van Hazel, Shem Patyna, Dongrui Ray Lu, Richard C. Chao, Eric Raymond

  pdf Download Poster (251 KB)

C28 - Efficacy Update on the First Real-World Experience of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Since US FDA Approval

Published in 2019 Listed under Clinical

Bhavana Konda; Sherry Mori Vogt; Sherise Rogers; Cassandra Grenade; Claire Verschraegen; Ye Zhou; Ashima Goyal; Mona Natwa; Chadwick Wright; Akram Hussein; Hallie Barr; Dramane Konate; Andrew Brown; Rochelle Batdorf; Bonnie Williams; Lai Wei; Manisha Shah

Abstract ID: 76

C28 - Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naïve or -Experienced Patients

Published in 2018 Listed under Clinical, Poster

Abstract ID: 94

Edward Wolin, George Fisher, Susan Pitman Lowenthal, Beloo Mirakhur, Rodney Pommier, Montaser Shaheen, Aaron Vinik

  pdf Download Poster (11.89 MB)

C28 – Outcomes After Liver Resection and Multidisciplinary Management of Gastroenteropancreatic Neuroendocrine Tumour Liver Metastases

Published in 2012 Listed under Clinical, Poster

Adam Fehr; Pankaj Bhatia; Daryl Gray; Walter Kocha; Robin Reid; James Elliott; Amol Mujoomdar; Christopher Howlett; Douglas Quan

  pdf Download Poster (650 KB)

C28 – Survival Analyses of Pancreatic Neuroendocrine Tumors: Contrasting Institutional Databases with Population-based Studies

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Thorvardur Halfdanarson MD H. Lee Moffitt Cancer Center, Tampa, Florida, USA ; University of Iowa, Iowa City, Iowa, USA

  pdf Download Poster (6.54 MB)

C28 – Cervical and Upper Mediastinal Lymph Node Metastasis from GI and Pancreatic Neuroendocrine Tumors: Incidence and Management

Published in 2011 Listed under Clinical, Poster

Yi-Zarn Wang DDS, MD, George Mayhall, Lowell Anthony MD, Richard Campeau MD, J. Philip Boudreaux MD, and Eugene Woltering MD

  pdf Download Poster (783 KB)

C29 - Safety and Response of an Evans Blue-Modified Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE with Increased Effective Dose in the Treatment Of Metastatic Neuroendocrine Tumors: A Pilot Prospective Study

Published in 2019 Listed under Clinical

Qingxing Liu; Yuejuan Cheng; Jie Zang Chinese; Hao Wang; Huimin Sui; Jingjing Zhang; Orit Jacobson; Zhaohui Zhu; Xiaoyuan Chen

Abstract ID: 88

C29 – Expectant Management of the Asymptomatic Primary is Safe in Patients Undergoing Chemoembolization for Metastatic Neuroendocrine Carcinoma

Published in 2010 Listed under Clinical

Tassone, Patrick; Arrese, David; Klemanski, Dori; Shah, Manisha; Schmidt, Carl; and Bloomston, Mark

C29 – Factors Associated with Octreotide LAR Use Among Elderly Patients with Carcinoid Syndrome: A Population-Based Analysis

Published in 2012 Listed under Clinical

Chan Shen; Ying Xu; Colleen C. Leary; James C. Yao; Ya-Chen Tina Shih